These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 19436123)

  • 1. Multicenter and retrospective case study of warfarin and aspirin combination therapy in patients with giant coronary aneurysms caused by Kawasaki disease.
    Suda K; Kudo Y; Higaki T; Nomura Y; Miura M; Matsumura M; Ayusawa M; Ogawa S; Matsuishi T
    Circ J; 2009 Jul; 73(7):1319-23. PubMed ID: 19436123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Warfarin therapy for giant aneurysm prevents myocardial infarction in Kawasaki disease.
    Sugahara Y; Ishii M; Muta H; Iemura M; Matsuishi T; Kato H
    Pediatr Cardiol; 2008 Mar; 29(2):398-401. PubMed ID: 18027010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and efficacy of warfarin plus aspirin combination therapy for giant coronary artery aneurysm secondary to Kawasaki disease: a meta-analysis.
    Su D; Wang K; Qin S; Pang Y
    Cardiology; 2014; 129(1):55-64. PubMed ID: 25116427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Six Kawasaki disease patients with acute coronary artery thrombosis].
    Zhou SL; Luo JP; Qi YQ; Liang YG; Wang W; Gong FQ
    Zhonghua Er Ke Za Zhi; 2013 Dec; 51(12):925-9. PubMed ID: 24495764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Warfarin plus aspirin or aspirin alone for patients with giant coronary artery aneurysms secondary to Kawasaki disease?
    Levin M; Burns JC; Gordon JB
    Cardiology; 2014; 129(3):174-7. PubMed ID: 25300244
    [No Abstract]   [Full Text] [Related]  

  • 6. Comment on the paper by Su et al. entitled 'safety and efficacy of warfarin plus aspirin combination therapy for giant coronary artery aneurysm secondary to kawasaki disease: a meta-analysis'.
    Loomba RS
    Cardiology; 2015; 130(3):164-5. PubMed ID: 25676566
    [No Abstract]   [Full Text] [Related]  

  • 7. [Prevention of thrombosis of coronary aneurysms in patients with a history of Kawasaki disease].
    Suda K; Kudo Y; Sugawara Y; Ishii M; Matsuishi T
    Nihon Rinsho; 2008 Feb; 66(2):355-9. PubMed ID: 18265459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Giant coronary thrombus as a complication of Kawasaki disease].
    Kádár K; Piskóthy A; Bendig L
    Orv Hetil; 1993 Oct; 134(44):2431-3. PubMed ID: 8233462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Longterm outcomes in patients with giant aneurysms secondary to Kawasaki disease.
    Levy DM; Silverman ED; Massicotte MP; McCrindle BW; Yeung RS
    J Rheumatol; 2005 May; 32(5):928-34. PubMed ID: 15868632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Thromboprophylaxis in patients with coronary aneurysms caused by Kawasaki disease].
    Suda K
    Nihon Rinsho; 2014 Sep; 72(9):1659-63. PubMed ID: 25518419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral anticoagulant thromboprophylaxis for Kawasaki disease.
    Newall F; Monagle P
    Pediatr Cardiol; 2006; 27(2):301. PubMed ID: 16132291
    [No Abstract]   [Full Text] [Related]  

  • 12. Rare refractory Kawasaki disease in an adolescent boy with cardiac and diffuse coronary artery involvement.
    Šileikienė R; Kudzytė J; Jankauskas A; Labanauskas L; Rakauskienė V; Jurkienė N; Kėvalas R
    Medicina (Kaunas); 2013; 49(7):341-5. PubMed ID: 24375247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Safety of warfarin therapy in children with coronary aneurysm due to Kawasaki disease].
    He XH; Zhu QL; Yuan YH; Long XD; Xia XH; Wang S; Hu C
    Zhonghua Er Ke Za Zhi; 2021 Feb; 59(2):95-100. PubMed ID: 33548954
    [No Abstract]   [Full Text] [Related]  

  • 14. [Evaluation of treatment and management of Kawasaki coronary artery disease based on clinical severity classification].
    Liu F; Zhao L; Wu L; Liang X; Chu C; He L; Huang G
    Zhonghua Er Ke Za Zhi; 2015 Sep; 53(9):690-5. PubMed ID: 26757970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Images in cardiovascular medicine. Giant coronary artery aneurysms in Kawasaki disease.
    Lilje C; Joyce JJ
    Circulation; 2005 Jun; 111(24):e440. PubMed ID: 15967855
    [No Abstract]   [Full Text] [Related]  

  • 16. [Kawasaki disease in children--9 years experience].
    Kowalczyk M; Kawalec W; Daszkowska-York J; Turska-Kmieć A; Brzezińska-Rajszys G; Sobielarska D; Ziółkowska L; Kościesza A; Jagiełłowicz D; Mirecka-Rola A
    Med Wieku Rozwoj; 2005; 9(2):179-93. PubMed ID: 16085959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A survey of the 3-decade outcome for patients with giant aneurysms caused by Kawasaki disease.
    Tsuda E; Hamaoka K; Suzuki H; Sakazaki H; Murakami Y; Nakagawa M; Takasugi H; Yoshibayashi M
    Am Heart J; 2014 Feb; 167(2):249-58. PubMed ID: 24439987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and Efficacy of Warfarin Therapy in Kawasaki Disease.
    Baker AL; Vanderpluym C; Gauvreau KA; Fulton DR; de Ferranti SD; Friedman KG; Murray JM; Brown LD; Almond CS; Evans-Langhorst M; Newburger JW
    J Pediatr; 2017 Oct; 189():61-65. PubMed ID: 28552449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impairment of angiogenic activity in the serum from patients with coronary aneurysms due to Kawasaki disease.
    Higashi K; Terai M; Hamada H; Honda T; Kanazawa M; Kohno Y
    Circ J; 2007 Jul; 71(7):1052-9. PubMed ID: 17587710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A registry study of Kawasaki disease patients with coronary artery aneurysms (KIDCAR): a report on a multicenter prospective registry study three years after commencement.
    Koyama Y; Miura M; Kobayashi T; Hokosaki T; Suganuma E; Numano F; Furuno K; Shiono J; Ebata R; Fuse S; Fukazawa R; Mitani Y
    Eur J Pediatr; 2023 Feb; 182(2):633-640. PubMed ID: 36434403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.